BRITAIN'S National Institute
for Health and Care Excellence
(NICE) has recommended the
PCSK9 inhibitors alirocumab and
evolocumab for patients with
primary hypercholesterolaemia
or mixed dyslipidaemia that is not
controlled with statins.
The update is part of final draft
guidance based on manufacturers
providing the drugs at discounted
prices.The above article was sent to subscribers in Pharmacy Daily's issue from 10 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 May 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.